DISCOVER presents treatment patterns

DISCOVER presents treatment patterns of type 2 diabetes in 32 countries at ADA 2017

 

Niklas Hammar from the DISCOVER Scientific Committee presented an insightful poster on Sunday 11 June at the 77th Scientific Sessions of the American Diabetes Association, that highlighted the global variation of treatment patterns in patients with type 2 diabetes.

 

ADA HbA1c control poster

DISCOVER presents new insights on glycaemic control

 

Professor Kamlesh Khunti of the DISCOVER Scientific Committee did an outstanding job of presenting the DISCOVER poster on glycaemic control in patients with type 2 diabetes at the 77th Scientific Sessions of the American Diabetes Association on Sunday 11 June.

 

DISCOVER presentation success at ADA 2017

DISCOVER presentation success at ADA 2017

 

Dr Mikhail Kosiborod of the DISCOVER Scientific Committee gave an excellent oral presentation on vascular complications in patients enrolled in DISCOVER on Monday 12 June at the 77th Scientific Sessions of the American Diabetes Association.

 

DISCOVER investigators assemble at ADA 2017

DISCOVER investigators assemble at ADA 2017

 

Investigators and Scientific Committee members held rewarding meetings at the 77th Scientific Sessions of the American Diabetes Association to catch up on all the latest developments, share their experiences and plan for the future of DISCOVER.

 

DISCOVER study publications update

Publication milestones for DISCOVER

 

The DISCOVER methods and rationale manuscript has been accepted for publication, and first baseline results will be presented at the 77th Scientific Sessions of the American Diabetes Association.

 

The DISCOVER study

 

DISCOVER is a global, prospective, observational study of patients with type 2 diabetes who are starting second-line glucose-lowering therapy. The study has enrolled over 15 000 patients in 38 countries across six continents, and will provide a comprehensive and contemporary picture of treatment patterns and outcomes in patients with type 2 diabetes worldwide.

 

Type 2 diabetes and real world evidence

 

The DISCOVER study is designed to generate real world evidence (RWE) about people living with type 2 diabetes across the globe. RWE is key to understanding more about type 2 diabetes and how it is managed in day-to-day clinical practice, and therefore contributes to improved disease management.

 

DISCOVER publications

 

The DISCOVER study will provide unprecedented global insights into the treatment of type 2 diabetes. The DISCOVER Scientific Committee is planning a series of abstracts, posters, presentations and journal articles about the DISCOVER study design and results at global, regional and local levels.

 

The DISCOVER study

The DISCOVER study

 

DISCOVER is a global, prospective, observational study of patients with type 2 diabetes who are starting second-line glucose-lowering therapy. The study has enrolled over 15 000 patients in 38 countries across six continents, and will provide a comprehensive and contemporary picture of treatment patterns and outcomes in patients with type 2 diabetes worldwide.

 
 

Type2 diabetes and real world evidence

Type 2 diabetes and real world evidence

The DISCOVER study is designed to generate real world evidence (RWE) about people living with type 2 diabetes across the globe. RWE is key to understanding more about type 2 diabetes and how it is managed in day-to-day clinical practice, and therefore contributes to improved disease management.

 

DISCOVER publications

DISCOVER publications

 

The DISCOVER study will provide unprecedented global insights into the treatment of type 2 diabetes. The DISCOVER Scientific Committee is planning a series of abstracts, posters, presentations and journal articles about the DISCOVER study design and results at global, regional and local levels.